Sonnet BioTherapeutics Quote - SONN

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.98

Bid

2.91

Offer

3.19

Volume

44,327

2.88 Day's Range 3.00

2.50 52 Week Range 18.7192

Market Cap

1.938M

Previous Close

2.89

Open

2.99

Last Trade

Last Trade Time

Financial Volume

US$ 130,438

VWAP

2.9426

Average Volume (3m)

500,259

Shares Outstanding

650,313

Dividend Yield

PE Ratio

-0.10

Earnings Per Share (EPS)

-28.96

Revenue

148k

Net Profit

-18.83M

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more

Sector

Pharmaceutical Preparations

Industry

Management Consulting Svcs

Website

www.sonnetbio.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was US$2.89. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of US$ 2.50 to US$ 18.7192.

Sonnet BioTherapeutics currently has 650,313 shares in issue. The market capitalisation of Sonnet BioTherapeutics is US$1.88 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.10.

Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment

Drs. Pankaj Mohan, CEO of Sonnet, and John Cini, CSO of Sonnet, discuss the Company’s recent issuance of a U.S. patent covering a variant of IL-18 incorporated into two novel immunotherapeutic...

Form 8-K - Current report

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form EFFECT - Notice of Effectiveness

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules

PRINCETON, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing innovative targeted...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form 8-K - Current report

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates

Both novel bifunctional (SON-1411) and monofunctional (SON-1400) fusion proteins exhibit wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable binding to the inhibitory...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form S-1 - General form for registration of securities under the Securities Act of 1933

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.005	-0.167504187605	2.985	3.5	2.5	159469	2.89593705	CS
4	-3.43	-53.5101404056	6.41	10	2.5	1346404	3.7026756	CS
12	-2.788	-48.3356449376	5.768	10	2.5	500259	3.93922516	CS
26	-10.94	-78.591954023	13.92	16	2.5	294229	4.57447431	CS
52	-7.74	-72.2014925373	10.72	18.7192	2.5	186116	6.59444123	CS
156	-1513.8584	-99.803538729	1516.8384	1649.4016	2.5	1912739	601.48155355	CS
260	-15323.1	-99.9805560195	15326.08	39916.8	2.5	2318628	2601.00928208	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	US$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	US$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	US$ 8.26 (89.02%)	2.03M
XCURExicure Inc	US$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	US$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	US$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	US$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	US$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	US$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	US$ 0.0201 (-0.50%)	425.38M
NVDANVIDIA Corporation	US$ 141.95 (-3.22%)	236.51M
SMCISuper Micro Computer Inc	US$ 33.15 (11.62%)	159.61M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5501 (-6.72%)	159.39M
SOUNSoundHound AI Inc	US$ 8.24 (18.05%)	107.91M